PACS — PACS Group, Inc.
—
NYSE ·
Health Care ·
Health Care Providers & Services ·
CIK 2001184 ·
Last close
$36.25
Market Cap
$5.74B
52W High
$42.53
52W Low
$29.35
ADV30
912,849
Next earnings
2026-08-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 1,420,494,000 | 250,427,000 | 120,035,000 | 80,695,000 | 5,663,518,000 | 247,981,000 | 4,621,328,000 |
| Dec 2025 | 1,357,979,000 | 223,557,000 | 94,687,000 | 59,702,000 | 5,584,034,000 | 197,016,000 | 4,631,585,000 |
| Sep 2025 | 1,344,567,000 | 203,198,000 | 86,269,000 | 52,406,000 | 5,626,892,000 | 355,672,000 | 4,749,976,000 |
| Jun 2025 | 1,309,236,000 | 194,009,000 | 80,499,000 | 50,963,000 | 5,502,169,000 | 294,173,000 | 4,689,501,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$490,315,000
Investing CF
$-374,570,000
Financing CF
$-132,639,000
CapEx
$-339,787,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$1.30
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$390,274,000
Inventory
—
Receivables
$733,220,000
ST Investments
—
EBIT TTM
$383,339,000
Pretax Income TTM
$355,456,000
Interest Exp TTM
$27,883,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,432,275,968
EBITDA
$442,524,992
Free Cash Flow
$303,311,360
Enterprise Value
$9,000,923,136
Total Cash
$247,980,992
Total Debt
$3,506,510,080
Shares Out
158,272,376
Trailing EPS
$1.55
Book Value
$6.60
ROE
27.1%
ROA
4.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 5,288,932,000 | 309,595,000 | 191,543,000 | 5,584,034,000 | 4,631,585,000 | — | 404,224,000 |
| Dec 2024 | 4,089,734,000 | 123,073,000 | 55,760,000 | 5,242,909,000 | 4,527,218,000 | — | 367,341,000 |
| Dec 2023 | 3,111,492,000 | 207,772,000 | 112,874,000 | 3,512,739,000 | 3,411,013,000 | — | 63,697,000 |
| Dec 2022 | 2,421,994,000 | 229,360,000 | 150,496,000 | 2,461,891,000 | 2,393,240,000 | — | 92,615,000 |
TTM Snapshot
Revenues TTM
$3,671,032,000
NetIncome TTM
$38,484,000
OpCashFlow TTM
$0
Assets (Latest)
$5,242,909,000
Forward EPS
$2.51
Max Pain — expiry 2026-06-18
max pain strike: $30.00 · spot: $35.89 · call oi: 12,066 · put oi: 2,602
Expected Move to 2026-06-18:
±$1.93
(5.36%) —
implied range
$33.96 –
$37.81
· ATM straddle on $35.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CHE | CHEMED CORP | $5.62B | $423.49 | — |
| CAI | Caris Life Sciences, Inc. | $5.14B | $18.18 | — |
| HIMS | Hims & Hers Health, Inc. | $6.73B | $30.17 | — |
| SHC | Sotera Health Co | $4.63B | $16.23 | — |
| RDNT | RadNet, Inc. | $4.49B | $57.05 | — |
News headlines (Yahoo Finance, 1h cache)
Is ENSG's Expanded $100M Buyback Program a Positive for Investors?
2026-06-16 18:15 · Yahoo
PACS Group's (NYSE:PACS) Performance Is Even Better Than Its Earnings Suggest
2026-05-18 11:07 · Yahoo
PACS Group Q1 Earnings Call Highlights
2026-05-14 08:05 · Yahoo
PACS Group (PACS) Is Up 22.1% After Q1 Beat, Guidance Hike and Buyback Launch
2026-05-14 04:38 · Yahoo
Assessing PACS Group (PACS) Valuation After Q1 Earnings Beat And New US$250 Million Buyback
2026-05-13 11:18 · Yahoo
Why PACS Group Stock Surged Today
2026-05-13 03:57 · Yahoo
PACS Group Inc (PACS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges
2026-05-12 23:04 · Yahoo
Stocks Settle Mixed on Tech Weakness and Inflation Pressures
2026-05-12 20:37 · Yahoo
Stocks Retreat as Oil Prices Surge and Inflation Accelerates
2026-05-12 15:16 · Yahoo
Stocks Pressured by Rising Oil Prices and Accelerating Inflation
2026-05-12 14:08 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.